Neurofix Pharma
PrivateLast Round
Crowdfunding
May 19, 2023
Est. Valuation
$23.79M
Total Funding Raised
$5.84M
Company Overview
Neurofix Pharma operates in Healthcare & Life Sciences and is based in Salamanca. Its latest recorded funding round was a Crowdfunding round in May 2023.
Neurofix Pharma is a biotechnology company that researches and develops lipid-based therapies for the treatment of central nervous system disorders, including neuropathic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurofix Pharma Comparables
Compare Neurofix Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReNetX Bio | 75% | |
| NervGen Pharma Corp. | 72% | |
| Neuroplast | 70% |
For institutional investors. Book with your work email.
Neurofix Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | May 19, 2023 | ||||
| VC Round | Nov 16, 2022 | ||||
| Crowdfunding | Jan 18, 2022 | ||||
| Crowdfunding | Sep 8, 2021 | ||||
| VC Round | Aug 14, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Neurofix Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nowture | VC Round |
| Fellow Funders | Crowdfunding |
| Capital Cell | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 18, 2022
Raised $4M led by Capital Cell
- Sep 8, 2021
$1.06M raised led by Fellow Funders
For institutional investors. Book with your work email.
Neurofix Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neurofix Pharma's valuation, stock price, and market status.
Is Neurofix Pharma a public or private company?
Neurofix Pharma is a private company.
What is the current stock price of Neurofix Pharma?
Neurofix Pharma is a private company, so its shares have no public market price. Caplight tracks Neurofix Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neurofix Pharma worth (valuation)?
Neurofix Pharma's valuation is estimated at $23.8M based on funding round data.
Can I buy Neurofix Pharma stock?
Neurofix Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neurofix Pharma's last funding round?
Neurofix Pharma's most recent funding round was Crowdfunding on May 19, 2023.
Who are the main investors in Neurofix Pharma?
Key investors in Neurofix Pharma include Nowture, Fellow Funders, Capital Cell.
Will Neurofix Pharma IPO soon?
No public IPO plans have been announced for Neurofix Pharma.
How can I track Neurofix Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Neurofix Pharma's shares on secondary markets.